Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 67Leukemia 28Precursor Cell Lymphoblastic Leukemia-Lymphoma 26Lymphoma 20Lymphoma, Follicular 14Congenital Abnormalities 14Lymphoma, Non-Hodgkin 13Recurrence 12Lymphoma, Large B-Cell, Diffuse 12Leukemia, Monocytic, Acute 12Myelodysplastic Syndromes 11Leukemia, Lymphocytic, Chronic, B-Cell 9Leukemia, Erythroblastic, Acute 9Prostatic Neoplasms 8Lymphoma, Large-Cell, Immunoblastic 8Leukemia, Myelomonocytic, Acute 8Leukemia, Megakaryoblastic, Acute 8Leukemia, Biphenotypic, Acute 8Lymphoma, Mantle-Cell 7Hodgkin Disease 5Burkitt Lymphoma 5Blast Crisis 5Lymphoma, B-Cell, Marginal Zone 3Leukemia, Promyelocytic, Acute 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Sarcoma, Myeloid 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Ovarian Neoplasms 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2

Interventions

fludarabine 2Cyclophosphamide 2thymoglobulin 1prednylidene 1ofatumumab 1deltacortene 1daratumumab 1carmustine, poliferprosan 20 drug combination 1Telemedicine 1Prednisone 1Peripheral Blood Stem Cell Transplantation 1Mitoxantrone 1Melphalan 1Immunologic Tests 1Immunoglobulins, Intravenous 1Etoposide 1Data Collection 1Cytarabine 1Carmustine 1Blood Specimen Collection 1Antilymphocyte Serum 1Alleles 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Autoimmune Diseases of the Nervous System × Mitoxantrone × Clear all
NCT00304291 2020-12-28

A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic's Disease)

State University of New York at Buffalo

Phase 4 Completed
5 enrolled

Myelitis, Transverse, Neuromyelitis Optica, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS

Data powered by HemOnc (CC BY 4.0) Colophon âš¡